期刊文献+

加强药学专业本科生生物标志物教学 被引量:5

Strengthening the teaching of biomarkers for pharmaceutical undergraduate
原文传递
导出
摘要 随着转化医学的发展,生物标志物在医药学的临床应用和基础研究中起着越来越重要的作用,不仅能够预测、发现、鉴别疾病的发生和进展,还可以用于药物基因组学,指导临床合理用药,并为新药研发提供思路和支持,是实现精准医疗的重要手段。本文从生物标志物的概念、发展、应用等方面,全面阐述生物标志物这个领域,帮助药学专业的学生更好的理解和掌握相关知识。 With the development of translational medicine, biomarkers play an increasingly important role in the clinical application and basic research of medicine, which can not only predict, detect and identify the occurrence and progression of diseases, but also be used in pharmacogenomics, guide the rational use of drugs in clinical practice, and provide ideas and support for the research and development of new drugs, which is an important means to achieve precision medicine. This article comprehensively elaborates the field of biomarkers from the aspects of the concept, development, and application of biomarkers to help pharmacy students better understand and master the relevant knowledge.
作者 张凤 邓易 金晓玲 陈万生 ZHANG Feng;DENG Yi;JIN Xiao-ling;CHEN Wan-sheng(Department of Pharmacy,Changzheng Hospital Second Military Medical University,Shanghai 200003,China)
出处 《中国医院药学杂志》 CAS 北大核心 2020年第5期586-589,共4页 Chinese Journal of Hospital Pharmacy
基金 国家自然科学基金项目(编号:81573793),国家国际科技合作专项(编号:S2015ZR1043),上海申康医院发展中心项目(编号:SHDC12015120)。
关键词 药学专业 精准化治疗 生物标志物 药物基因组学 pharmacy precision therapy biomarker pharmacogenomics
  • 相关文献

参考文献5

二级参考文献30

  • 1Wen MS, Lee M, Chen J J, et al. Prospective study of warfarin dosage requirements based on CYP2C9 and VKORCI geno types[J]. Clin Pharamacol Ther,2008,84(1 ) :83-89.
  • 2Ohno M, Yamamoto A, Ono A, et al. Influence of clinical and genetic factors on warfarin dose requirements among Japanese patients[J]. Eur J Clin Pharamacol,2009,65 (11 ) : 1097-1103.
  • 3Aomori T, Obayashi K, Fujita and vitamin K oxide reductase Y, et al. Influence of CYP2C9 complex (VKORC) 1 polymor phisms on time to determine the warfarin maintenance dose [J]. Pharmazie,2011,66(3) :222-225.
  • 4Klein TE, Altman RB, Eriksson N, et al. Estimation of the warfarin dose with clinical and pharmaeogenetic data[J]. N En gl J Med,20119,360(8):753-764.
  • 5Mikheeva IuA, Kropacheva ES, Ignat'ev IV, et al. Cytochrome P4502C9 (CYP2Cg)gene polymorphism and safety of therapy with warfarin[J]. Kardiologiia, 2008,48 (3) : 52-57.
  • 6Aomori T, Obayashi K, Fujita Y, et al. Influence of CYP2C9 and vitamin K oxide reductase complex(VKORC)1 polymor- phisms on time to determine the warfarin maintenance dose [J]. Pharmazie,2011,66(3):22-225.
  • 7Yang L, Ge W, Yu F, et al. Impact of VKORC1 gene polymor phism on inter-individual and interethnic warfarin dosage requirement-a systematic review and meta analysis [J]. Thromh Res,2010,125(4) : e159-e166.
  • 8顾强,陈柏成,郝嘉,王学锋,肖颖彬.重庆地区人工机械瓣膜置换术后患者VKORC1-1639A/G遗传基因多态性与华法林剂量调整的研究[J].第三军医大学学报,2009,31(23):2370-2373. 被引量:12
  • 9张婷,胡永芳.中国人群华法林药效与细胞色素P4502C9基因多态性关系的系统评价和荟萃分析[J].中国临床药理学杂志,2009,25(6):526-529. 被引量:9
  • 10葛卫红,于锋,阳丽梅.基因多态性与华法林剂量需求关系的研究进展[J].中国临床药理学杂志,2010,26(3):226-230. 被引量:9

共引文献46

同被引文献42

引证文献5

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部